Jiangsu gdk Biotechnology Co., Ltd.
SSE:688670.SS
13.52 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.464 | 42.555 | 35.611 | -1.73 | 4.367 | 19.122 | -6.299 | 20.923 | 106.22 | 98.126 | 203.965 | 3.927 | 12.468 | 43.41 | 316.768 | 2.049 | 30.045 | 326.739 | 174.952 | 46.259 | 41.149 |
| Cost of Revenue
| 0.165 | 9.163 | 12.74 | 7.681 | 0.631 | 9.18 | -1.148 | 5.733 | 16.099 | 18.053 | 30.72 | 0.48 | 1.335 | 19.339 | 33.125 | 0.522 | 4.193 | 36.107 | 23.794 | 5.388 | 8.381 |
| Gross Profit
| 3.299 | 33.391 | 22.871 | -9.411 | 3.736 | 9.942 | -5.151 | 15.19 | 90.121 | 80.073 | 173.245 | 3.447 | 11.133 | 24.072 | 283.643 | 1.528 | 25.851 | 290.631 | 151.158 | 40.871 | 32.768 |
| Gross Profit Ratio
| 0.952 | 0.785 | 0.642 | 5.44 | 0.855 | 0.52 | 0.818 | 0.726 | 0.848 | 0.816 | 0.849 | 0.878 | 0.893 | 0.555 | 0.895 | 0.745 | 0.86 | 0.889 | 0.864 | 0.884 | 0.796 |
| Reseach & Development Expenses
| 7.542 | 19.03 | 2.894 | 8.484 | 3.2 | 3.423 | 5.602 | 3.347 | 3.1 | 7.548 | 6.445 | 15.467 | 2.95 | 6.398 | 8.352 | 14.693 | 5.816 | 6.492 | 8.172 | 5.909 | 7.961 |
| General & Administrative Expenses
| 14.61 | -21.069 | 28.88 | -7.247 | 25.14 | -36.219 | 45.069 | -10.151 | 14.791 | -24.656 | 31.529 | -5.554 | 11.675 | -16.139 | 23.188 | 2.876 | 2.642 | -10.285 | 16.967 | 15.07 | 2.405 |
| Selling & Marketing Expenses
| 3.599 | 6.422 | 23.905 | 4.395 | 4.454 | 21.437 | 2.315 | 13.312 | 40.009 | 30.79 | 69.579 | 2.026 | 5.099 | 0.966 | 103.433 | -0.052 | 11.927 | 116.254 | 54.374 | 19.912 | 18.593 |
| SG&A
| 18.209 | -26.215 | 52.785 | 8.323 | 29.987 | -14.781 | 47.384 | 3.161 | 54.8 | 6.134 | 101.107 | -3.529 | 16.774 | -15.173 | 126.62 | 2.824 | 14.569 | 105.969 | 71.341 | 34.982 | 20.998 |
| Other Expenses
| 0.19 | 84.68 | -18.207 | -0.013 | -0.069 | -84.083 | 0.006 | -0.121 | -0.448 | 41.946 | -19.534 | 14.243 | 0.167 | 0.012 | 0.012 | 0.004 | 0.006 | 0.003 | -0.001 | -0.834 | 0.02 |
| Operating Expenses
| 25.94 | 77.332 | 37.472 | 16.82 | 33.256 | 84.083 | 31.411 | 25.859 | 57.453 | 55.627 | 88.018 | 26.182 | 19.891 | 23.71 | 118.553 | 20.706 | 29.046 | 137.355 | 69.044 | 46.229 | 25.361 |
| Operating Income
| -22.641 | -45.67 | -14.601 | -24.501 | -29.52 | -64.961 | -57.446 | -0.504 | 41.24 | -13.423 | 74.35 | -22.735 | -8.758 | -36.568 | 147.727 | -20.989 | -6.203 | 141.461 | 73.568 | -8.411 | 5.124 |
| Operating Income Ratio
| -6.537 | -1.073 | -0.41 | 14.163 | -6.76 | -3.397 | 9.12 | -0.024 | 0.388 | -0.137 | 0.365 | -5.789 | -0.702 | -0.842 | 0.466 | -10.242 | -0.206 | 0.433 | 0.421 | -0.182 | 0.125 |
| Total Other Income Expenses Net
| 0.464 | -4.67 | -0.407 | -0.068 | 3.688 | -4.298 | 0.006 | -0.121 | -0.491 | -0.481 | -0.068 | 11.036 | 0.011 | 0.012 | 0.012 | 0.004 | 0.006 | 0.003 | -0.001 | -5.934 | 0.02 |
| Income Before Tax
| -22.178 | -52.057 | -15.008 | -22.852 | -25.832 | -65.167 | -57.44 | -0.624 | 40.749 | -13.904 | 74.282 | -11.699 | -0.27 | -36.556 | 147.739 | -20.985 | -6.197 | 141.465 | 73.566 | -9.246 | 5.144 |
| Income Before Tax Ratio
| -6.403 | -1.223 | -0.421 | 13.21 | -5.915 | -3.408 | 9.119 | -0.03 | 0.384 | -0.142 | 0.364 | -2.979 | -0.022 | -0.842 | 0.466 | -10.239 | -0.206 | 0.433 | 0.42 | -0.2 | 0.125 |
| Income Tax Expense
| -4.596 | -12.016 | -2.413 | -3.476 | -4.342 | -9.345 | -11.282 | 0.641 | 4.403 | 0.167 | 1.408 | 2.918 | 2.371 | -18.941 | 24.358 | -2.974 | -0.902 | 34.904 | 18.338 | 1.732 | 0.975 |
| Net Income
| -17.581 | -40.041 | -12.594 | -19.377 | -21.49 | -54.702 | -46.158 | -1.265 | 36.346 | -14.071 | 72.874 | -14.616 | -2.642 | -17.615 | 123.38 | -18.01 | -5.295 | 106.56 | 55.228 | -10.978 | 4.169 |
| Net Income Ratio
| -5.076 | -0.941 | -0.354 | 11.201 | -4.921 | -2.861 | 7.328 | -0.06 | 0.342 | -0.143 | 0.357 | -3.722 | -0.212 | -0.406 | 0.389 | -8.788 | -0.176 | 0.326 | 0.316 | -0.237 | 0.101 |
| EPS
| -0.14 | -0.33 | -0.1 | -0.16 | -0.17 | -0.44 | -0.37 | -0.01 | 0.3 | -0.11 | 0.83 | -0.17 | -0.03 | -0.22 | 2.1 | -0.31 | -0.064 | 1.81 | 0.94 | -0.32 | 0.086 |
| EPS Diluted
| -0.14 | -0.33 | -0.1 | -0.16 | -0.17 | -0.44 | -0.37 | -0.01 | 0.3 | -0.11 | 0.83 | -0.17 | -0.03 | -0.22 | 2.1 | -0.31 | -0.064 | 1.81 | 0.94 | -0.32 | 0.086 |
| EBITDA
| -21.889 | -34.735 | -14.677 | -16.923 | -17.817 | -60.927 | -50.226 | 7.592 | 48.989 | -5.984 | 82.152 | -3.335 | 7.995 | -28.929 | 157.808 | -16.591 | 4.211 | 144.641 | 76.686 | -4.749 | 10.722 |
| EBITDA Ratio
| -6.319 | -0.816 | -0.412 | 9.782 | -4.08 | -3.186 | 7.974 | 0.363 | 0.461 | -0.061 | 0.403 | -0.849 | 0.641 | -0.666 | 0.498 | -8.095 | 0.14 | 0.443 | 0.438 | -0.103 | 0.261 |